Get started
Author

Laura G. Gonzalez-Malerva

Observed names: L Gonzalez-Malerva, L. Gonzalez-Malerva, Laura Gonzalez-Malerva, Laura Gonzalez‐Malerva, Laura González Malerva, Laura González‐Malerva
Observed institutions: Harvard University, Tianjin Medical University Cancer Institute and Hospital, Mayo Clinic in Arizona, Arizona State University, Tianjin Medical University, Universidad Nacional Autónoma de México
OpenAlex ID: A5019701921
High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy
2011 · Laura Gonzalez-Malerva, Jaehong Park, et al. · Proceedings of the National Academy of Sciences · 106
In situ drug-receptor binding kinetics in single cells: a quantitative label-free study of anti-tumor drug resistance
2014 · Wei Wang, Linliang Yin, et al. · Scientific Reports · 49
PDF
Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner
2018 · Femina Rauf, Fernanda Festa, et al. · Oncogene · 46
PDF
Actin expression in Taenia solium cysticerci (cestoda): tisular distribution and detection of isoforms
2003 · Javier R. Ambrosio, Olivia Reynoso‐Ducoing, et al. · Cell Biology International · 22
Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants
2023 · Anasuya Pal, Laura Gonzalez-Malerva, et al. · npj Breast Cancer · 16
PDF
Kinome-level screening identifies inhibition of polo-like kinase-1 (PLK1) as a target for enhancing non-viral transgene expression
2015 · Matthew D. Christensen, Jacob J. Elmer, et al. · Journal of Controlled Release · 12
Muscular myosin isoforms of Taenia solium (Cestoda)
2004 · Laura Gonzalez‐Malerva, Mayra Cruz‐Rivera, et al. · Cell Biology International · 8
Abstract P4-05-07: Functional genomics of TP53 mutations and its impact in breast cancer progression
2015 · Anasuya Pal, Laura Gonzalez-Malerva, et al. · Cancer Research · 2
Abstract P1-02-05: A genome-wide functional genomics screen reveals unique co-driver mutations of mutant TP53 promoting cellular heterogeneity during breast cancer progression
2022 · Dustin Grief, Anasuya Pal, et al. · Cancer Research · 1
Abstract 4493: Germline findings in targeted tumor sequencing using matched normal DNA
2016 · Subha Krishnan, Gargi D. Basu, et al. · Cancer Research · 1
Abstract P5-04-19: JAK2 copy number and targeted JAK2 inhibition of TNBC cell lines
2016 · M Chen, M Andreozzi, et al. · Cancer Research · 1
Abstract P2-11-20: Discovering Co-driver Genes and Pathways of Mutant TP53 in Breast Cancer by CRISPR Screening and Multi-omics Approaches
2025 · Lilian Nwachukwu, Anasuya Pal, et al. · Clinical Cancer Research
Abstract B061: Discovering co-driver genes and pathways of mutant TP53 in breast cancer by CRISPR screening and multi-omics approaches
2024 · Lilian Nwekwo, Anasuya Pal, et al. · Cancer Research
Abstract P1-08-05: Discovering drug targets for aggressive breast cancer with TP53 missense mutations by a genome-wide screen
2017 · A Pal, J Park, et al. · Cancer Research
ARID1A alterations in gynecological cancers as a therapeutic opportunity.
2016 · Laura Gonzalez-Malerva, Gargi D. Basu, et al. · Journal of Clinical Oncology
Abstract P6-03-15: Inhibition of breast cancer tumor cell lines by simvastatin is dependent on specific p53 mutation
2016 · SR Ferdosi, H Grewal, et al. · Cancer Research
Abstract C299: Functional differences of mutant p53's expressed in MCF10A cells and their contribution to breast carcinogenesis.
2013 · Laura G. Gonzalez-Malerva, Seron Eaton, et al. · Molecular Cancer Therapeutics
Abstract 5124: Genomic and proteomic characterization of tamoxifen sensitive and resistant MCF7 cells
2012 · Laura G. Gonzalez-Malerva, Jin Park, et al. · Cancer Research
Autophagy and Tamoxifen Resistance in Breast Cancer.
2009 · L. Gonzalez-Malerva, J. Park, et al. · Cancer Research
Una mirada al interior de las células. Citoesqueleto
2003 · Laura González Malerva, Javier Hernández Ambrosio · Ciencias (México, D.F.)
Works count: 20
Citation count: 264
H-index: 7
I10-index: 6
Year
Topic
Type